Showing results (71-80 of 1,085) with videos related to
Sort By:
Pageof 109
Arteriosclerosis, Thrombosis, and Vascular Biology|January 24, 2004
Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemiaRosemarijn Renckens, Sebastiaan Weijer, Alex F de Vos, et al.Critical Care Medicine|November 3, 2006
Salmeterol enhances pulmonary fibrinolysis in healthy volunteersNico A Maris, Alex F de Vos, Paul Bresser, et al.Journal of the American Geriatrics Society|April 4, 2008
Cognitive, functional, and quality-of-life outcomes of patients aged 80 and older who survived at least 1 year after planned or unplanned surgery or medical intensive care treatmentSophia E J A de Rooij, Annerike C Govers, Johanna C Korevaar, et al.Critical Care Medicine|May 9, 2012
Endogenous tissue-type plasminogen activator impairs host defense during severe experimental Gram-negative sepsis (melioidosis)*Liesbeth M Kager, W Joost Wiersinga, Joris J T H Roelofs, et al.American Journal of Respiratory Cell and Molecular Biology|April 19, 2008
Endogenous beta-adrenergic receptors inhibit lipopolysaccharide-induced pulmonary cytokine release and coagulationIda A J Giebelen, Masja Leendertse, Mark C Dessing, et al.Critical Care Medicine|April 7, 2007
Recombinant human activated protein C inhibits local and systemic activation of coagulation without influencing inflammation during Pseudomonas aeruginosa pneumonia in ratsGoda Choi, Jorrit-Jan H Hofstra, Joris J T H Roelofs, et al.Scandinavian Journal of Infectious Diseases|June 19, 2002
Diabetes insipidus as a complication of cryptococcal meningitis in an HIV-infected patientNicole P Juffermans, Annelies Verbon, Tom Van der PollCritical Care (London, England)|February 8, 2008
Targeting RAGE in sepsisMarieke A D van Zoelen, Tom van der PollDiabetes|May 30, 2006
Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humansMichiel E Stegenga, Saskia N van der Crabben, Marcel Levi, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
Plasminogen activator inhibitor type-1-deficient mice have an enhanced IFN-gamma response to lipopolysaccharide and staphylococcal enterotoxin BRosemarijn Renckens, Jennie M Pater, Tom van der PollPageof 109